Bloqueo del sistema renina-angiotensina-aldosterona en hipertensión arterial, diabetes y nefropatía
R Marín, R Álvarez-Navascués… - Revista española de …, 2008 - Elsevier
El bloqueo del sistema renina-angiotensina con fármacos inhibidores de la enzima de
conversión de la angiotensina o con antagonistas de los receptores de la angiotensina II ha …
conversión de la angiotensina o con antagonistas de los receptores de la angiotensina II ha …
[PDF][PDF] Prevention of left ventricular remodeling after myocardial infarction: efficacy of physical training
C Taglieri, E Lombardo, M Feola - Monaldi archives for chest …, 2008 - monaldi-archives.org
Post-myocardial infarction left ventricular remodelling should be considered an important
therapeutic target in patients after an acute myocardial infarction, considering the heavy …
therapeutic target in patients after an acute myocardial infarction, considering the heavy …
Perioperative Modifikation der Dauermedikation bei kardiovaskulären, pulmonalen und metabolischen Erkrankungen
A Redel, U Schwemmer - AINS-Anästhesiologie …, 2008 - thieme-connect.com
Ein großer und weiter zunehmender Anteil der Patienten, die sich dem Anästhesisten im
Rahmen der Prämedikationsvisite vorstellen, nimmt täglich Medikamente zur Therapie oder …
Rahmen der Prämedikationsvisite vorstellen, nimmt täglich Medikamente zur Therapie oder …
Prevention of macrovascular disease in type 2 diabetic patients: blockade of the renin-angiotensin-aldosterone system
GN Thomas, B Tomlinson - Current diabetes reviews, 2008 - ingentaconnect.com
Type 2 diabetes is reaching epidemic proportions throughout the world, which has major
health implications as such patients have considerably increased risk of coronary heart …
health implications as such patients have considerably increased risk of coronary heart …
[PDF][PDF] Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need
S Lim - Acta Med Indones, 2008 - inaactamedica.org
The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in both cardiac and
renal injury. Inhibition of RAAS with either an angiotensin converting enzyme inhibitor (ACE …
renal injury. Inhibition of RAAS with either an angiotensin converting enzyme inhibitor (ACE …
Tissue factor modulation by Angiotensin II: a clue to a better understanding of the cardiovascular effects of renin-angiotensin system blockade?
A Celi, AD Fiorentino, S Cianchetti… - … , Metabolic & Immune …, 2008 - ingentaconnect.com
Systemic hypertension, a pathological process to which the renin-angiotensin system
contributes importantly, is characterized by a thrombophilic diathesis and an increased risk …
contributes importantly, is characterized by a thrombophilic diathesis and an increased risk …
Hyperkalemia risk and treatment of heart failure
J Segura, LM Ruilope - Heart Failure Clinics, 2008 - Elsevier
Hyperkalemia Risk and Treatment of Heart Failure - ScienceDirect Skip to main contentSkip
to article Elsevier logo Journals & Books Help Search My account Sign in View PDF …
to article Elsevier logo Journals & Books Help Search My account Sign in View PDF …